Epilepsy drug during pregnancy does not increase risk of infant disability

A new study, published in the The British Journal of Clinical Pharmacology, examined whether the use of epilepsy drug, lamotrigine, during pregnancy increased the risk of birth malformations or neurodevelopmental disorders.

Advertisement

Researchers studied the children of 83 epileptic women, who took lamotrigine during pregnancy between 2004 and 2014. They monitored the infants and gave the parents a questionnaire to complete regarding their child’s development and health, up to the age of 12.

The study shows the children did not suffer from birth malformations or neurodevelopmental disorders.

More articles on healthcare quality: 
11M men have oral HPV in US 
3 research needs for the creation of a universal flu vaccine 
Ebola vaccines candidates display efficacy in clinical trial

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.